NGL Fine-Chem Live BSE/NSE | NGL Fine-Chem Fundamenta data | NGL Fine-Chem Balance sheet | NGL Fine-Chem Quarterly Results | NGL Fine-Chem Profit & Loss

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

561.40
44.34
5

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

586.47
0.19%
5.18

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

10 Years
5 Years
3 Years

15.71
9.59
10.22

EBITDA CAGR (%)

10 Years
5 Years
3 Years

14.69
-0.98
-0.61

PAT CAGR (%)

10 Years
5 Years
3 Years

15.97
-1.44
-5.67

P:E (Median)

8 Years
5 Years
3 Years

-
-
35.92

P:BV (Average)

8 Years
5 Years
3 Years

0.27
0.84
3.82

EV:EBITDA (Average)

8 Years
5 Years
3 Years

1.13
3.50
16.04

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var% Sep 19 Sep 18 Var%
Net Sales 42 41 4% 35 43 -18% 37 34 9% 37 39 -4%
Expenses 30 32 -7% 33 33 1% 34 27 24% 33 32 2%
EBITDA 13 9 46% 2 11 -79% 4 7 -48% 5 7 -32%
EBIDTM 30% 21% 6% 25% 10% 21% 13% 18%
Other Income 2 1 67% 1 1 -27% 1 1 74% 1 2 -42%
Interest 1 0 40% 1 1 13% 1 1 0% 1 1 12%
Depreciation 2 2 7% 2 2 16% 2 2 17% 2 1 19%
PBT 12 8 59% 1 10 -93% 3 6 -55% 3 7 -50%
Tax 4 2 56% 1 3 -83% 1 2 -68% 0 2 -83%
PAT 9 6 60% 0 7 -98% 2 4 -50% 3 4 -33%
PATM 21% 14% 0% 16% 5% 12% 8% 11%
EPS 14.31 8.94 60% 0.23 10.98 -98% 3.26 6.57 -50% 4.80 7.13 -33%

Description Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var% Sep 19 Sep 18 Var%
Net Sales 42 41 4% 35 0 0 37 34 9% 37 39 -4%
Expenses 29 32 -10% 33 0 0 34 27 26% 33 32 3%
EBITDA 13 8 59% 2 0 0 3 7 -56% 4 7 -38%
EBIDTM 32% 21% 6% 0% 9% 21% 12% 18%
Other Income 2 1 61% 1 0 0 1 1 63% 1 2 -42%
Interest 1 0 25% 1 0 0 1 1 0% 1 1 27%
Depreciation 2 2 12% 2 0 0 2 2 27% 2 1 32%
PBT 13 7 74% 0 0 0 2 6 -71% 3 7 -59%
Tax 4 2 57% 1 0 0 1 2 -67% 0 2 -83%
PAT 9 5 81% 0 0 - 1 4 -72% 2 4 -47%
PATM 22% 13% -1% 0% 3% 12% 6% 11%
EPS 15.14 8.38 81% -0.30 0.00 - 1.82 6.57 -72% 3.78 7.13 -47%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated

Description TTM Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Net Sales 153 152 153 114 100 96 88 79 56 36 35 Net Sales Growth -3% -1% 35% 14% 4% 9% 12% 42% 54% 2% Cost Of Goods Sold 65 65 63 46 38 41 42 40 29 19 17 Gross Profit 87 87 91 68 62 55 47 39 27 17 19 GP Margin 57% 57% 59% 60% 62% 58% 53% 49% 48% 48% 53% Total Expenditure 129 131 121 92 74 74 73 68 48 32 30 Power & Fuel Cost - 10 9 6 4 4 4 4 4 3 2 % Of Sales - 7% 6% 5% 4% 4% 5% 6% 8% 8% 7% Employee Cost - 24 21 18 14 11 9 8 6 4 4 % Of Sales - 16% 14% 16% 14% 12% 11% 10% 11% 10% 10% Manufacturing Exp. - 17 13 12 10 9 9 8 6 4 5 % Of Sales - 11% 9% 10% 10% 9% 10% 10% 10% 11% 13% General & Admin Exp. - 6 5 4 4 3 3 2 1 1 1 % Of Sales - 4% 3% 4% 4% 3% 3% 2% 3% 3% 3% Selling & Distn. Exp. - 5 5 4 3 5 5 4 1 1 1 % Of Sales - 3% 3% 4% 3% 5% 6% 5% 2% 3% 3% Miscellaneous Exp. - 5 5 2 1 1 1 1 1 1 1 % Of Sales - 3% 3% 1% 1% 1% 1% 1% 1% 2% 1% EBITDA 23 21 32 22 25 22 15 11 8 4 5 EBITDA Margin 15% 14% 21% 19% 26% 23% 17% 14% 14% 11% 15% Other Income 5 3 4 3 1 0 0 0 0 0 0 Interest 2 3 3 2 1 2 2 2 1 1 1 Depreciation 7 7 6 5 3 3 3 2 2 1 1 PBT 19 14 28 18 23 18 11 7 4 2 4 Tax 5 4 7 5 8 6 5 2 2 1 1 Tax Rate 26% 26% 27% 29% 35% 36% 35% 32% 35% 33% 37% PAT 14 11 20 13 15 11 8 5 3 1 2 PAT before Minority Interest 14 11 20 13 15 11 8 5 3 1 2 Minority Interest 0 0 0 0 0 0 0 0 0 0 0 PAT Margin 9% 7% 13% 11% 15% 12% 9% 6% 5% 3% 7% PAT Growth -33% -47% 59% -15% 31% 37% 84% 56% 177% -56% EPS 22.58 17.10 32.47 20.37 24.02 18.39 13.44 7.31 4.69 1.69 3.89

Description

TTM

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Net Sales

153

152

153

114

100

Net Sales Growth

-3%

-1%

35%

14%

12%

42%

54%

Cost Of Goods Sold

Gross Profit

GP Margin

57%

59%

60%

62%

58%

53%

49%

48%

53%

Total Expenditure

129

131

121

Power & Fuel Cost

% Of Sales

Employee Cost

% Of Sales

16%

14%

16%

14%

12%

11%

10%

11%

10%

Manufacturing Exp.

% Of Sales

11%

10%

11%

13%

General & Admin Exp.

% Of Sales

Selling & Distn. Exp.

% Of Sales

Miscellaneous Exp.

% Of Sales

EBITDA

EBITDA Margin

15%

14%

21%

19%

26%

23%

17%

14%

11%

15%

Other Income

Interest

Depreciation

PBT

Tax

Tax Rate

26%

27%

29%

35%

36%

35%

32%

35%

33%

37%

PAT

PAT before Minority Interest

Minority Interest

PAT Margin

13%

11%

15%

12%

PAT Growth

-33%

-47%

59%

-15%

31%

37%

84%

56%

177%

-56%

EPS

22.58

17.10

32.47

20.37

24.02

18.39

13.44

7.31

4.69

1.69

3.89

Description TTM Mar 20 Mar 19
Net Sales - 152 153 Net Sales Growth - -1% Cost Of Goods Sold - 64 63 Gross Profit - 87 91 GP Margin - 58% 59% Total Expenditure - 132 121 Power & Fuel Cost - 10 9 % Of Sales - 7% 6% Employee Cost - 24 21 % Of Sales - 16% 14% Manufacturing Exp. - 17 13 % Of Sales - 11% 9% General & Admin Exp. - 6 5 % Of Sales - 4% 3% Selling & Distn. Exp. - 5 5 % Of Sales - 3% 3% Miscellaneous Exp. - 5 5 % Of Sales - 3% 3% EBITDA - 20 32 EBITDA Margin - 13% 21% Other Income - 3 4 Interest - 3 3 Depreciation - 8 6 PBT - 12 28 Tax - 4 7 Tax Rate - 31% 27% PAT - 8 20 PAT before Minority Interest - 8 20 Minority Interest - 0 0 PAT Margin - 6% 13% PAT Growth - -59% EPS - 13.45 32.47

Description

TTM

Mar 20

Mar 19

Net Sales

152

153

Net Sales Growth

-1%

Cost Of Goods Sold

Gross Profit

GP Margin

58%

59%

Total Expenditure

132

121

Power & Fuel Cost

% Of Sales

Employee Cost

% Of Sales

16%

14%

Manufacturing Exp.

% Of Sales

11%

General & Admin Exp.

% Of Sales

Selling & Distn. Exp.

% Of Sales

Miscellaneous Exp.

% Of Sales

EBITDA

EBITDA Margin

13%

21%

Other Income

Interest

Depreciation

PBT

Tax

Tax Rate

31%

27%

PAT

PAT before Minority Interest

Minority Interest

PAT Margin

13%

PAT Growth

-59%

EPS

13.45

32.47

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Shareholder's Funds 101 92 72 59 44 33 25 20 17 16 Share Capital 3 3 3 3 3 3 3 3 3 3 Total Reserves 98 89 69 56 41 30 21 17 14 13 Non-Current Liabilities 12 12 17 13 2 3 5 4 4 2 Secured Loans 8 8 12 9 0 2 3 3 4 2 Unsecured Loans 0 0 0 0 0 0 0 0 0 0 Long Term Provisions 2 1 1 2 0 0 0 0 0 0 Current Liabilities 48 45 44 39 32 31 27 23 16 13 Trade Payables 21 16 24 14 14 17 12 12 8 7 Other Current Liabilities 6 6 5 4 2 2 2 2 2 1 Short Term Borrowings 15 15 11 11 12 10 11 9 5 4 Short Term Provisions 7 8 4 9 3 2 1 1 1 1 Total Liabilities 161 149 133 111 78 67 56 47 37 32 Net Block 61 61 56 25 24 17 19 18 10 11 Gross Block 81 74 64 28 38 29 29 25 16 15 Accumulated Depreciation 20 13 7 3 13 11 10 8 6 4 Non Current Assets 73 63 73 52 28 22 20 18 18 14 Capital Work in Progress 0 0 3 16 2 1 0 0 5 1 Non Current Investment 4 0 0 0 0 0 0 0 2 2 Long Term Loans & Adv. 8 2 13 11 2 4 2 1 1 1 Other Non Current Assets 0 0 0 0 0 0 0 0 0 0 Current Assets 88 86 60 59 50 44 35 29 20 18 Current Investments 11 9 6 6 3 2 0 0 0 0 Inventories 28 19 17 12 10 12 8 10 6 5 Sundry Debtors 26 33 28 30 32 26 24 15 11 11 Cash & Bank 3 3 4 2 2 2 1 2 1 1 Other Current Assets 20 7 1 0 2 2 2 3 2 2 Short Term Loans & Adv. 14 16 4 9 2 2 2 2 1 1 Net Current Assets 40 41 16 20 18 13 9 6 4 5 Total Assets 161 149 133 111 78 67 56 47 37 32

Description

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Shareholder's Funds

101

Share Capital

Total Reserves

Non-Current Liabilities

Secured Loans

Unsecured Loans

Long Term Provisions

Current Liabilities

Trade Payables

Other Current Liabilities

Short Term Borrowings

Short Term Provisions

Total Liabilities

161

149

133

111

Net Block

Gross Block

Accumulated Depreciation

Non Current Assets

Capital Work in Progress

Non Current Investment

Long Term Loans & Adv.

Other Non Current Assets

Current Assets

Current Investments

Inventories

Sundry Debtors

Cash & Bank

Other Current Assets

Short Term Loans & Adv.

Net Current Assets

Total Assets

161

149

133

111

Description Mar 20 Mar 19
Shareholder's Funds 99 92 Share Capital 3 3 Total Reserves 96 89 Non-Current Liabilities 12 12 Secured Loans 8 8 Unsecured Loans 0 0 Long Term Provisions 2 1 Current Liabilities 49 45 Trade Payables 21 16 Other Current Liabilities 6 6 Short Term Borrowings 15 15 Short Term Provisions 7 8 Total Liabilities 159 149 Net Block 68 61 Gross Block 92 74 Accumulated Depreciation 24 13 Non Current Assets 73 63 Capital Work in Progress 0 0 Non Current Investment 0 0 Long Term Loans & Adv. 5 2 Other Non Current Assets 0 0 Current Assets 87 86 Current Investments 11 9 Inventories 28 19 Sundry Debtors 26 33 Cash & Bank 3 3 Other Current Assets 19 7 Short Term Loans & Adv. 12 16 Net Current Assets 38 41 Total Assets 159 149

Description

Mar 20

Mar 19

Shareholder's Funds

Share Capital

Total Reserves

Non-Current Liabilities

Secured Loans

Unsecured Loans

Long Term Provisions

Current Liabilities

Trade Payables

Other Current Liabilities

Short Term Borrowings

Short Term Provisions

Total Liabilities

159

149

Net Block

Gross Block

Accumulated Depreciation

Non Current Assets

Capital Work in Progress

Non Current Investment

Long Term Loans & Adv.

Other Non Current Assets

Current Assets

Current Investments

Inventories

Sundry Debtors

Cash & Bank

Other Current Assets

Short Term Loans & Adv.

Net Current Assets

Total Assets

159

149

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Cash From Operating Activity 20 9 22 10 8 8 0 0 1 4 PBT 14 28 18 23 18 13 7 4 2 4 Adjustment 11 8 5 3 3 3 2 2 1 1 Changes in Working Capital -2 -19 4 -8 -6 -4 -7 -5 -1 1 Cash after chg. in Working capital 23 16 28 18 15 12 2 2 2 6 Interest Paid 0 0 0 0 0 0 0 0 0 0 Tax Paid -4 -7 -5 -8 -6 -5 -2 -2 -1 -1 Other Direct Exp. Paid 0 0 0 0 0 0 0 0 0 0 Extra & Other Items 0 0 0 0 0 0 0 0 0 0 Cash From Investing Activity -20 -10 -21 -10 -10 -3 -4 -3 -4 -6 Net Fixed Assets -7 -7 -23 -5 -9 -1 -4 -5 -5 -5 Net Investments -6 -2 0 -3 -1 -2 0 1 0 -1 Others -7 0 2 -3 1 0 0 0 0 0 Cash from Financing Activity 0 0 0 0 2 -4 3 4 3 1 Net Cash Inflow / Outflow 0 -1 1 0 0 1 -1 1 0 0 Opening Cash & Equivalents 1 1 0 0 2 1 2 1 1 1 Closing Cash & Equivalent 0 1 1 0 2 2 1 2 1 1

Description

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Cash From Operating Activity

PBT

Adjustment

Changes in Working Capital

-2

-19

-8

-6

-4

-7

-5

-1

Cash after chg. in Working capital

Interest Paid

Tax Paid

-4

-7

-5

-8

-6

-5

-2

-1

Other Direct Exp. Paid

Extra & Other Items

Cash From Investing Activity

-20

-10

-21

-10

-3

-4

-3

-4

-6

Net Fixed Assets

-7

-23

-5

-9

-1

-4

-5

Net Investments

-6

-2

-3

-1

-2

-1

Others

-7

-3

Cash from Financing Activity

-4

Net Cash Inflow / Outflow

-1

Opening Cash & Equivalents

Closing Cash & Equivalent

Description Mar 20 Mar 19
Cash From Operating Activity 20 9 PBT 12 28 Adjustment 12 8 Changes in Working Capital 0 -19 Cash after chg. in Working capital 24 16 Interest Paid 0 0 Tax Paid -4 -7 Other Direct Exp. Paid 0 0 Extra & Other Items 0 0 Cash From Investing Activity -21 -10 Net Fixed Assets -7 Net Investments -6 Others -8 Cash from Financing Activity 0 0 Net Cash Inflow / Outflow 0 -1 Opening Cash & Equivalents 1 1 Closing Cash & Equivalent 0 1

Description

Mar 20

Mar 19

Cash From Operating Activity

PBT

Adjustment

Changes in Working Capital

-19

Cash after chg. in Working capital

Interest Paid

Tax Paid

-4

-7

Other Direct Exp. Paid

Extra & Other Items

Cash From Investing Activity

-21

-10

Net Fixed Assets

-7

Net Investments

-6

Others

-8

Cash from Financing Activity

Net Cash Inflow / Outflow

-1

Opening Cash & Equivalents

Closing Cash & Equivalent

Financial Ratios

Standalone /

Consolidated

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Book Value (Rs.) 164 149 117 96 72 53 40 32 28 26 ROA 7% 14% 10% 16% 16% 14% 9% 7% 3% 8% ROE 11% 25% 19% 29% 30% 29% 20% 16% 6% 16% ROCE 14% 28% 22% 34% 37% 33% 22% 19% 11% 22% Fixed Asset Turnover 1.96 2.23 2.53 3.25 3.12 3.33 3.15 2.92 2.39 3.02 Receivable days 71 72 91 107 103 95 84 81 108 91 Inventory Days 56 42 45 37 39 39 39 48 52 43 Payable days 48 59 72 64 68 68 61 70 83 70 Cash Conversion Cycle 79 55 65 81 74 65 62 59 76 65 Total Debt/Equity 0.28 0.29 0.37 0.38 0.33 0.40 0.68 0.67 0.60 0.39 Interest Cover 6 12 11 24 12 9 5 4 2 7

Description

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Book Value (Rs.)

164

149

117

ROA

14%

10%

16%

14%

ROE

11%

25%

19%

29%

30%

29%

20%

16%

ROCE

14%

28%

22%

34%

37%

33%

22%

19%

11%

22%

Fixed Asset Turnover

1.96

2.23

2.53

3.25

3.12

3.33

3.15

2.92

2.39

3.02

Receivable days

107

103

108

Inventory Days

Payable days

Cash Conversion Cycle

Total Debt/Equity

0.28

0.29

0.37

0.38

0.33

0.40

0.68

0.67

0.60

0.39

Interest Cover

Description Mar 20 Mar 19
Book Value (Rs.) 160 149 ROA 5% 13% ROE 9% 22% ROCE 12% 25% Fixed Asset Turnover 1.83 2.07 Receivable days 71 79 Inventory Days 56 44 Payable days 48 48 Cash Conversion Cycle 79 75 Total Debt/Equity 0.29 0.29 Interest Cover 6 12

NGL Fine-Chem Ltd.

Pharmaceuticals & Drugs

BSE: 524774 | NSE: Not Listed

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Standalone Figures in Rs. Crores /

Results Balance Sheet

Standalone Figures in Rs. Crores /

Cash Flow

Standalone Figures in Rs. Crores /

Financial Ratios

Standalone /

Annual Reports:

News Update

NGL Fine-Chem Ltd.

Pharmaceuticals & Drugs

BSE: 524774 | NSE: Not Listed

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Standalone Figures in Rs. Crores /

Results Balance Sheet

Standalone Figures in Rs. Crores /

Cash Flow

Standalone Figures in Rs. Crores /

Financial Ratios

Standalone /

Annual Reports:

News Update